EV/EBITDA
0.37
+0.01+2.78%
10 min ago
Summary
- As of February 7, 2025, ACHL EV/EBITDA is 0.37, with a rise of +0.01 (+2.78%) during the most recent trading day.
- Over the past year, ACHL EV/EBITDA has dropped by -0.84 (-69.42%).
- ACHL EV/EBITDA is now -83.91% below its all-time high of 2.30.
Performance
ACHL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ACHL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.8% | -1.6% | -0.7% |
| 1 m1 month | -22.9% | +23.3% | +16.0% |
| 3 m3 months | -35.1% | +35.8% | +33.9% |
| 6 m6 months | -57.5% | +56.6% | +80.4% |
| ytdytd | -27.4% | +27.7% | +21.1% |
| 1 y1 year | -69.4% | +71.4% | +53.2% |
| 5 y5 years | - | - | - |
ACHL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -30.2% | 0.36 | +2.8% | |
| 3 m | 3-month | 0.61 | -39.3% | 0.36 | +2.8% |
| 6 m | 6-month | 0.89 | -58.4% | 0.36 | +2.8% |
| 1 y | 1-year | 1.21 | -69.4% | 0.36 | +2.8% |
| 3 y | 3-year | 2.30 | -83.9% | 0.36 | +2.8% |
| 5 y | 5-year | 2.30 | -83.9% | -14.31 | +102.6% |
| alltime | all time | 2.30 | -83.9% | -14.31 | +102.6% |
Achilles Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.37(-27.5%) |
| 2024 | 0.51(-58.2%) |
| Date | Value |
|---|---|
| 2023 | 1.22(-27.8%) |
| 2022 | 1.69(+103.6%) |
| 2021 | 0.83 |
FAQ
- What is Achilles Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Achilles Therapeutics?
- What is ACHL EV/EBITDA year-to-date change?
- What is Achilles Therapeutics EV/EBITDA year-on-year change?
What is Achilles Therapeutics EV/EBITDA?
The current EV/EBITDA of ACHL is 0.37
What is the all time high EV/EBITDA for Achilles Therapeutics?
Achilles Therapeutics all-time high EV/EBITDA is 2.30
What is ACHL EV/EBITDA year-to-date change?
Achilles Therapeutics EV/EBITDA has changed by -0.14 (-27.45%) since the beginning of the year
What is Achilles Therapeutics EV/EBITDA year-on-year change?
Over the past year, ACHL EV/EBITDA has changed by -0.84 (-69.42%)